
Ostera is a startup dedicated to improving success rates in assisted reproduction treatments by leveraging cutting-edge scientific discoveries and technologies. Their core offering, OsteraTest, integrates gene expression and artificial intelligence to identify oocytes with the highest potential for developing into promising embryos. This advanced methodology assists doctors, embryologists, and patients in making informed decisions about treatments, ultimately aiming to increase the chances of a successful pregnancy. Ostera also engages in research and development to optimize assisted reproduction processes and offers consulting services to fertility clinics. Their business model likely involves a per-test fee or a subscription for clinic access to their technology, focusing on enhancing patient outcomes in fertility preservation and family planning.

Ostera is a startup dedicated to improving success rates in assisted reproduction treatments by leveraging cutting-edge scientific discoveries and technologies. Their core offering, OsteraTest, integrates gene expression and artificial intelligence to identify oocytes with the highest potential for developing into promising embryos. This advanced methodology assists doctors, embryologists, and patients in making informed decisions about treatments, ultimately aiming to increase the chances of a successful pregnancy. Ostera also engages in research and development to optimize assisted reproduction processes and offers consulting services to fertility clinics. Their business model likely involves a per-test fee or a subscription for clinic access to their technology, focusing on enhancing patient outcomes in fertility preservation and family planning.